Company Filing History:
Years Active: 1992-1993
Title: Michael B O'Connell: Innovator in Agglutination Reaction Devices
Introduction
Michael B O'Connell is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of agglutination reaction devices, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of immunoassay reactions.
Latest Patents
O'Connell's latest patents include innovative devices designed for performing agglutination immunoassay reactions. One of his patents describes an agglutination reaction device featuring geometrically modified chambers. This device includes a first hydrophilic layer, a second liquid-occlusive layer, and a third layer with a transparent opening for observing particles. The unique geometry of the chamber allows for a non-random pattern of aggregated particles, enhancing the visibility of results.
Another patent details an improved agglutination reaction device that utilizes selectively impregnated porous materials. This device features a chamber with a proximate zone and a distal zone, where agglutination reactions can occur. The layer of liquid absorbent material is strategically impregnated to control the overall rate of liquid flow, optimizing the reaction process.
Career Highlights
Michael B O'Connell is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced technologies that enhance diagnostic capabilities.
Collaborations
Throughout his career, O'Connell has collaborated with notable colleagues, including Kevin J Forney and Robert G Parsons. These collaborations have contributed to the advancement of his innovative projects and patents.
Conclusion
Michael B O'Connell is a distinguished inventor whose work in agglutination reaction devices has made a significant impact in the field of immunoassays. His innovative patents and contributions to Abbott Laboratories Corporation highlight his commitment to advancing healthcare technology.